Found 266 matching trials
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
PHASE2Researchers conducting this study hope to learn about the safety and effect...
Location
University of Chicago Comprehensive Cancer Center
Lp(a) Lowering Study of Pelacarsen (TQJ230) in Patients in the US With Elevated Lp(a) and Recent ACS (STEMI/NSTEMI) - Lp(a)FRONTIERS PEARL
PHASE3CTQJ230A1US13 is a randomized, double-blind, placebo-controlled, multicente...
Location
Multiple Locations
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
PHASE1This is a randomized, double blind, placebo-controlled, single site, trial ...
Location
Fred Hutchinson Cancer Research Center
Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial
PHASE2Chronic pain symptoms are very common among U.S. Military Veterans and have...
Location
Durham VA Medical Center, Durham, NC
Use of Cidofovir for Recurrent Respiratory Papillomatosis
PHASE4Recurrent respiratory papillomatosis (RRP) is the most common benign neopla...
Location
Multiple Locations
Safety and Efficacy of the Novel Selective Nicotinic Receptor Partial Agonist, CHANTIX (Varenicline) in Patients With Acute Coronary Syndrome
PHASE4Assess the role of a nicotine antagonist in helping patients presenting to ...
Location
Newark Beth Israel Medical Center
Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain
PHASE3The purposes of this study are to determine whether an investigational drug...
Location
Multiple Locations
Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes
PHASE3The objective of the current study is to investigate the efficacy, safety a...
Location
1218.20.10033 Boehringer Ingelheim Investigational Site
Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease
PHASE3This 12-month study had two phases: a 90-day double-blind, randomized, plac...
Location
Rivercity Research
The OBstetric Lidocaine Patch (OBLido) Trial
PHASE4This study will be a single-center, single blind, randomized controlled tri...
Location
UnityPoint Health-Meriter Hospital